Distinguished in Ulcerative Colitis

Oren D. Ledder

Jerusalem, JM, IL 
Distinguished in Ulcerative Colitis
Jerusalem, JM, IL 
OverviewLocationsClinical Research

Overview

Oren Ledder practices in Jerusalem, Israel. Mr. Ledder is rated as a Distinguished expert by MediFind in the treatment of Ulcerative Colitis. His top areas of expertise are Colitis, Viral Gastroenteritis, Crohn's Disease, Endoscopy, and Gastrostomy.

His clinical research consists of co-authoring 81 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 32 articles and participated in 1 clinical trial in the study of Ulcerative Colitis.

Gender
Male

Locations

Jerusalem, JM, Israel

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Predicting Response to Vedolizumab in Pediatric Inflammatory Bowel Diseases (IBD) Including Drug Levels: a Multi-center Prospective Cohort Study, From the Pediatric IBD Porto Group of European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN)
Predicting Response to Vedolizumab in Pediatric Inflammatory Bowel Diseases (IBD) Including Drug Levels: a Multi-center Prospective Cohort Study, From the Pediatric IBD Porto Group of European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN)
Enrollment Status: Completed
Publish Date: October 25, 2022
Intervention Type: Drug
Study Drug: Vedolizumab
Study Phase: Not Applicable
The Role of Ursodeoxycholic Acid in Treatment of Gallstones in Hemolytic Disorders
The Role of Ursodeoxycholic Acid in Treatment of Gallstones in Hemolytic Disorders
Enrollment Status: Terminated
Publish Date: October 10, 2017
Intervention Type: Drug
Study Phase: Phase 4
View 1 Less Clinical Trial

81 Total Publications

Validation of prediction models for anti-tumor necrosis factor treatment response in pediatric Crohn's disease: a systematic review and prospective cohort study.
Validation of prediction models for anti-tumor necrosis factor treatment response in pediatric Crohn's disease: a systematic review and prospective cohort study.
Journal: Journal of Crohn's & colitis
Published: September 19, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Ledder's expertise for a condition
ConditionClose
    View All 12 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile